Since JNK-, ERK1/2, and NF-κB/ BCR signaling plays an important role in the development of DLBCL [29,30,31], it could be speculated that the growth inhibitory effects of WK1 might also be mediated by the suppression of these ways. The gene discussed is MAPK3; the disease is diffuse large B-cell lymphoma.